Henry Sonneborn
Henry Sonneborn publishes mostly in Oncology, Molecular Biology and Dermatology, on topics such as Cancer Treatment and Pharmacology, Cancer therapeutics and mechanisms and Chemotherapy-related skin toxicity.
- World rank
- #4,333,023 of 7,710,434 ranked researchers
- Rank in United States
- #1,162,439 of 1,627,098
- Works
- 15
- Citations
- 409
- Citations per work
- 27.3
What does Henry Sonneborn research?
Henry Sonneborn's work is mostly in Medicine (59%), Biochemistry, Genetics and Molecular Biology (14%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences959.5%
- Medicine959.5%
- Everything else426.2%
- Life Sciences214.3%
- 1Oncology24% of their works
- 2Molecular Biology14% of their works
- 3Dermatology12% of their works
- 4Pulmonary and Respiratory Medicine12% of their works
- 5Epidemiology7% of their works
- 6Cardiology and Cardiovascular Medicine5% of their works
Research topics
Which keywords describe Henry Sonneborn's research?
The keywords of their largest research topics: Chemotherapy, Clinical Trials, Prevention, Targeted Therapy, Chemotherapy-Induced Peripheral Neuropathy, Taxanes, Dermatological Toxicity and DNA.
- Pancreatic Neuroendocrine Tumors
- International Myeloma Working Group
- Diagnosis Criteria
- Small-Cell Lung Cancer
- EGFR Mutations
- Topoisomerases
- Dermatological Toxicity
- Taxanes
- Targeted Therapy
- Clinical Trials
- Chemotherapy
- Prevention
- Chemotherapy-Induced Peripheral Neuropathy
- DNA
- Extravasation
- ALK Inhibitors
- Genomic Profiles
- Anthracyclines
- Doxorubicin
- Neuroendocrine Tumors
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 20 words, with their numbers
- Chemotherapy134 topics
- Clinical Trials62 topics
- Prevention62 topics
- Targeted Therapy62 topics
- Chemotherapy-Induced Peripheral Neuropathy51 topic
- Taxanes51 topic
- DNA41 topic
- Dermatological Toxicity41 topic
- Extravasation41 topic
- Topoisomerases41 topic
- ALK Inhibitors31 topic
- EGFR Mutations31 topic
- Genomic Profiles31 topic
- Small-Cell Lung Cancer31 topic
- Anthracyclines21 topic
- Diagnosis Criteria21 topic
- Doxorubicin21 topic
- International Myeloma Working Group21 topic
- Neuroendocrine Tumors21 topic
- Pancreatic Neuroendocrine Tumors21 topic
Where does Henry Sonneborn work?
Henry Sonneborn's main affiliation in the publication record is Deaconess Hospital, United States.
How many publications and citations does Henry Sonneborn have?
OpenAlex counts 15 works and 409 citations for Henry Sonneborn, an h-index of 9, ranking #4,333,023 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Henry Sonneborn. Posts are plain text and can be reported.